⌘K

Home/Filings/4/0001171843-18-000687

4//SEC Filing

Ahn Edward S. 4

Accession 0001171843-18-000687

CIK 0000898437other

View on SEC.gov Company Profile

Filed

Jan 25, 7:00 PM ET

Accepted

Jan 26, 4:05 PM ET

Size

5.4 KB

Accession

0001171843-18-000687

Insider Transaction Report

Form 4

Period: 2018-01-24

Anika Therapeutics, Inc.ANIK

Chief Tech. & Strategy Officer

Transactions

Award
Stock Option (Right to Buy)
2018-01-24+13,400→ 13,400 total
Exercise: $61.47Exp: 2028-01-24→ Common Stock (13,400 underlying)

Footnotes (1)

[F1]The stock options vest in four equal annual installments beginning January 24, 2019.

Documents

1 file

4
formfour.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Anika Therapeutics, Inc.

CIK 0000898437

Entity typeother

Related Parties

1

filerCIK 0001623597

Filing Metadata

Form type: 4
Filed: Jan 25, 7:00 PM ET
Accepted: Jan 26, 4:05 PM ET
Size: 5.4 KB

View on SEC.gov